Literature DB >> 22938934

Imaging of thyrotoxicosis.

Jennifer A Sipos1, George J Kahaly.   

Abstract

The diagnostic algorithm for patients with Graves' disease frequently involves the use of thyroid autoantibody testing and radioisotope scanning (full text available online: http://education.amjmed.com/pp1/248). However, ultrasound has myriad uses in the evaluation of patients with hyperthyroidism. The purpose of this paper is to review the medical literature outlining the important role that ultrasonography (US) can play in the diagnosis and management of patients with hyperthyroidism. We will make a case for the use of ultrasonography in the initial evaluation of all patients with thyrotoxicosis. This review will delineate the advantages of ultrasonography compared to nuclear medicine imaging in determining the etiology of the hyperthyroidism. The role of sonography in predicting remission and relapse of Graves' disease will also be examined. Finally, this paper will detail the importance of ultrasonography in the workup of hyperthyroidism during pregnancy. We will also outline its utility for predicting fetal thyroid dysfunction in maternal Graves' disease without the need for cordocentesis and its attendant complications.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938934     DOI: 10.1016/j.amjmed.2012.05.012

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  2 in total

1.  A 2015 Italian Survey of Clinical Practice Patterns in the Management of Graves' Disease: Comparison with European and North American Surveys.

Authors:  Roberto Negro; Roberto Attanasio; Franco Grimaldi; Rinaldo Guglielmi; Enrico Papini
Journal:  Eur Thyroid J       Date:  2016-03-12

2.  Role of Diffusion-Weighted Magnetic Resonance (MR) Imaging in Differentiation Between Graves' Disease and Painless Thyroiditis.

Authors:  Ahmed Abdel Khalek Abdel Razek; Sieza Samir Abd Allah; Amr Abd El-Hamid El-Said
Journal:  Pol J Radiol       Date:  2017-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.